	Survival Probability in % (95% Confidence Interval)
	Test Population		White		Black		Other		Unkown
	n	%	n	%	n	%	n	%	n	%
	5-Year Survival
All Cases	20,793	70.7%	17,148	70.6%	1459	67.0%	1985	73.0%	201	88.3%
Age at diagnosis
0 - 19 years	13,920	88.8%	11,459	89.0%	967	85.6%	1333	89.0%	161	95.5%
20 - 39 years	2549	46.4%	2089	46.0%	174	37.4%	260	56.3%	26	48.7%
40 - 59 years	2348	30.9%	1937	30.7%	190	26.8%	212	36.2%	9	75.2%
>60 years	1976	17.4%	1663	17.1%	128	18.4%	180	18.2%	5	40.0%
Sex
Male	11,642	70.2%	9667	70.0%	801	68.4%	1056	72.8%	118	84.7%
Female	9151	71.4%	7481	71.5%	658	65.2%	929	73.3%	83	92.9%
All phenotypes
T-cell	1344	62.0%	998	63.9%	200	56.0%	136	56.5%	10	78.8%
B-cell	15,131	71.4%	12,608	71.1%	956	70.6%	1452	73.7%	115	90.8%
Unknown lineage	1940	68.9%	1650	69.4%	133	54.8%	141	75.1%	16	73.9%
Other	2378	70.3%	1892	68.4%	170	67.4%	256	85.2%	60	--
	10-Year Survival
All Cases	20,793	67.5%	17,148	67.3%	1459	63.2%	1985	70.5%	201	88.3%
Age at diagnosis
0 - 19 years	13,920	86.1%	11,459	86.3%	967	82.5%	1333	86.3%	161	95.5%
20 - 39 years	2549	41.7%	2089	41.2%	174	31.2%	260	53.9%	26	--
40 - 59 years	2348	26.1%	1937	25.4%	190	23.1%	212	34.1%	9	75.2%
>60 years	1976	11.3%	1663	11.0%	128	8.1%	180	15.0%	5	--
Sex
Male	11,642	66.6%	9667	66.3%	801	64.3%	1056	70.0%	118	84.7%
Female	9151	68.6%	7481	68.7%	658	62.0%	929	71.0%	83	92.9%
All phenotypes
T-cell	1344	60.3%	998	62.3%	200	53.1%	136	55.1%	10	78.8%
B-cell	15,131	68.0%	12,608	67.6%	956	66.4%	1452	71.2%	115	90.8%
Unknown lineage	1940	66.0%	1650	66.6%	133	52.5%	141	71.4%	16	73.9%
Other	2378	70.3%	1892	68.4%	170	67.4%	256	85.2%	60	--